Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CYT005-AllQbG10 in Grass-Pollen Allergy
NCT00293904Phase 2Completed
- Sponsor
- Cytos Biotechnology AG
- Start
- Feb 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of CYT005-AllQbG10 in Seasonal Allergic Rhinoconjunctivitis (SAR), sponsored by Cytos Biotechnology AG. Started Feb 2006; status: completed.
02
Drugs
CYT005-AllQbG10
03
Conditions
Seasonal Allergic Rhinoconjunctivitis (SAR)
Beyond the preview
Go deeper on NCT00293904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00293904.